Hi there!
We track 49,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Cambridge Cancer Genomics
Cambridge Cancer Genomics develops precision oncology solutions to transform the way cancer patients are treated. Using simple blood draws, CCG shortens the time required to know whether treatment is…
Cambridge Cancer Genomics
Cambridge Cancer Genomics develops precision oncology solutions to transform the way cancer patients are treated. Using simple blood draws, CCG shortens the time required to know whether treatment is…
TL;DR
What they do: Blood-based precision oncology monitoring to detect relapse, predict therapy response, and shorten time to know if treatment is working
Founded / HQ: Founded 2016; headquartered in Cambridge, England
Founders / leadership: Co‑founders include John Cassidy, Evaline Tsai, Harry Clifford, Nirmesh Patel
Funding signal: Raised seed-stage funding (notable round Dec 2018); total funding reported between $4.62M and $8.5M in different sources
Exit: Acquired by Dante Labs in June 2021
Company Overview
Problem Domain
Oncology diagnostics / treatment monitoring
Founded
2016
Industry
Health / Biotechnology / Precision Oncology
Funding Track Record
$4.5M
Reported as a significant round in December 2018 (Dealroom)
Investor Signal
“Investors reported include Soma Capital, Refactor, Romulus Capital, Y Combinator, AME Cloud Ventures, Pi Campus and FundersClub”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 49,000+ startups and their open roles. No spam. No gamification. Just jobs.
49,000+
Startups
44,000+
Open Roles
0+
New This Week